Instan a suspender patentes de vacunas
May 7, 2021 - EUA se une a India y Sudáfrica en la propuesta de suspensión temporal de patentesde vacunas contra la COVID para que cualquier fabricante del mundo produzca sus propias copias sin temor de infringir derechos de propiedad intelectual
Germany has opposed this, claiming manufacturing capacity and high quality standards are limiting production, not patents, while Pfizer CEO Albert Bourla has said theirs are the only facilties that can manufacture
mRNA vaccines. However, a number of other EU states including Spain have expressed cautious support for the U.S. proposal.
Pharmaceutical investors have also warned against the move, claiming
that it could discourage investment in these companies, just as the industry has proved that they are the only ones capable of delivering a solution to the crisis.